Variability of ferritin measurements in chronic kidney disease; implications for iron management

被引:47
作者
Ford, Bradley A. [1 ]
Coyne, Daniel W. [2 ]
Eby, Charles S. [1 ,2 ]
Scott, Mitchell G. [1 ]
机构
[1] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA
[2] Washington Univ, Dept Med, St Louis, MO 63110 USA
关键词
ferritin; iron; hemodialysis; anemia; ANEMIC HEMODIALYSIS-PATIENTS; HIGH SERUM FERRITIN; INTRAVENOUS IRON; TRANSFERRIN SATURATION; DIALYSIS PATIENTS; IV IRON; DEFICIENCY; GLUCONATE; TRIAL; REDUCTION;
D O I
10.1038/ki.2008.526
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Serum ferritin levels are a proxy measure of iron stores; existing guidelines for managing anemia in hemodialysis patients suggest that serum ferritin concentrations should be maintained at > 200 ng/ml. The KDOQI recommendations further state there is insufficient evidence advocating routine intravenous iron when ferritin levels exceed 500 ng/ml. Here we determined the interassay differences and short-term intraindividual variability of serum ferritin measurements in patients on chronic hemodialysis to illustrate how these variances may affect treatment decisions. Intermethod variations of up to 150 ng/ml were found comparing six commonly used ferritin assays that evaluated thirteen pools of serum from hemodialysis and nonhemodialysis patients. The intraindividual variability for ferritin in 60 stable hemodialysis patients ranged between 2-62% measured over an initial two-week period and from 3-52% when factored over a six-week period. Our results suggests that single serum ferritin values should not be used to guide clinical decisions regarding treatment of chronic hemodialysis patients with intravenous iron due to significant analytical and intraindividual variability.
引用
收藏
页码:104 / 110
页数:7
相关论文
共 31 条
[1]   SERUM FERRITIN AND TRANSFERRIN SATURATION IN PATIENTS WITH CHRONIC-ALCOHOLIC AND NONALCOHOLIC LIVER-DISEASES [J].
BELL, H ;
SKINNINGSRUD, A ;
RAKNERUD, N ;
TRY, K .
JOURNAL OF INTERNAL MEDICINE, 1994, 236 (03) :315-322
[2]  
Besarab A, 2000, J AM SOC NEPHROL, V11, P530, DOI 10.1681/ASN.V113530
[3]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[4]  
Bock JL, 2005, ARCH PATHOL LAB MED, V129, P323
[5]   DAY-TO-DAY VARIATION IN IRON-STATUS INDEXES IN HEALTHY-MEN AND WOMEN [J].
BOREL, MJ ;
SMITH, SM ;
DERR, J ;
BEARD, JL .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1991, 54 (04) :729-735
[6]   Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients [J].
Canavese, C ;
Bergamo, D ;
Ciccone, G ;
Longo, F ;
Fop, F ;
Thea, A ;
Martina, G ;
Piga, A .
KIDNEY INTERNATIONAL, 2004, 65 (03) :1091-1098
[7]  
Chang CH, 2002, CLIN NEPHROL, V57, P136
[8]   SERUM TRANSFERRIN RECEPTOR [J].
COOK, JD ;
SKIKNE, BS ;
BAYNES, RD .
ANNUAL REVIEW OF MEDICINE, 1993, 44 :63-74
[9]   Iron indices: What do they really mean? [J].
Coyne, D .
KIDNEY INTERNATIONAL, 2006, 69 :S4-S8
[10]   Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: Results of the dialysis patients' response to IV iron with elevated ferritin (DRIVE) study [J].
Coyne, Daniel W. ;
Kapoian, Toros ;
Suki, Wadi ;
Singh, Ajay K. ;
Moran, John E. ;
Dahl, Naomi V. ;
Rizkalal, Adel R. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (03) :975-984